Qiyun Ou

1.3k total citations
24 papers, 544 citations indexed

About

Qiyun Ou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Qiyun Ou has authored 24 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Qiyun Ou's work include Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (7 papers) and Advanced Breast Cancer Therapies (4 papers). Qiyun Ou is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (7 papers) and Advanced Breast Cancer Therapies (4 papers). Qiyun Ou collaborates with scholars based in China, Hong Kong and Macao. Qiyun Ou's co-authors include Yunfang Yu, Dongqiang Zeng, Herui Yao, Yongjian Chen, Anlin Li, Dagui Lin, Qiugen Hu, Xiaoyin Li, Chuanmiao Xie and Shengbo Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncotarget.

In The Last Decade

Qiyun Ou

21 papers receiving 538 citations

Peers

Qiyun Ou
Audrey Hennequin France
Laure Hirsch France
Muhammad Zubair Afzal United States
Osvaldo Arén Frontera United States
Emily Roarty United States
Yiming Mao China
R. Houston Thompson United Kingdom
Jonathan Derman France
Valentina Tateo Italy
Audrey Hennequin France
Qiyun Ou
Citations per year, relative to Qiyun Ou Qiyun Ou (= 1×) peers Audrey Hennequin

Countries citing papers authored by Qiyun Ou

Since Specialization
Citations

This map shows the geographic impact of Qiyun Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiyun Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiyun Ou more than expected).

Fields of papers citing papers by Qiyun Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiyun Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiyun Ou. The network helps show where Qiyun Ou may publish in the future.

Co-authorship network of co-authors of Qiyun Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Qiyun Ou. A scholar is included among the top collaborators of Qiyun Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiyun Ou. Qiyun Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ou, Qiyun, Kevin Lu, Dongqiang Zeng, et al.. (2024). Unraveling the influence of metabolic signatures on immune dynamics for predicting immunotherapy response and survival in cancer. SHILAP Revista de lepidopterología. 3(2). 2 indexed citations
3.
4.
Ouyang, Wenhao, Tiantian Tang, Linjie Huang, et al.. (2022). A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 758777–758777. 31 indexed citations
5.
6.
Zhou, Haiyu, Shaopeng Zheng, Anlin Li, et al.. (2020). Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study). EClinicalMedicine. 24. 100422–100422. 17 indexed citations
7.
Ou, Qiyun, Yunfang Yu, Anlin Li, et al.. (2020). Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma. Annals of Translational Medicine. 8(5). 230–230. 18 indexed citations
8.
Li, Anlin, Yongjian Chen, Qiyun Ou, et al.. (2020). Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers. SHILAP Revista de lepidopterología. 10(2). e92–e92. 7 indexed citations
9.
Yu, Yunfang, Wenda Zhang, Anlin Li, et al.. (2020). Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer. JAMA Network Open. 3(4). e202149–e202149. 75 indexed citations
10.
11.
Ou, Qiyun, Yunfang Yu, Anlin Li, et al.. (2019). Association of immune-related adverse events with immune checkpoint inhibitor efficacy in pancancer.. Journal of Clinical Oncology. 37(15_suppl). e14087–e14087. 1 indexed citations
12.
Ou, Qiyun, Ying Tang, Sha Fu, et al.. (2019). Corticosteroids combined with doublet or single-agent immunosuppressive therapy for active proliferative lupus nephritis. Clinical Rheumatology. 38(9). 2519–2528. 3 indexed citations
13.
Yu, Yunfang, Dongqiang Zeng, Qiyun Ou, et al.. (2019). Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non–Small Cell Lung Cancer. JAMA Network Open. 2(7). e196879–e196879. 200 indexed citations
14.
Ou, Qiyun, Yunfang Yu, Anlin Li, et al.. (2019). Surrogate end points for overall survival in patients with advanced non-small-cell lung cancer in trials of immunotherapy.. Journal of Clinical Oncology. 37(15_suppl). e14122–e14122. 1 indexed citations
15.
Ou, Qiyun, et al.. (2018). Comprehensive analyses of the clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer.. Journal of Clinical Oncology. 36(5_suppl). 168–168. 1 indexed citations
16.
Yu, Yunfang, et al.. (2018). Comparative efficacy and acceptability of first-line single-agent chemotherapy in metastatic breast cancer.. Journal of Clinical Oncology. 36(15_suppl). e13082–e13082. 1 indexed citations
17.
Yu, Yunfang, et al.. (2018). Benefits and risks from maintenance therapy after first-line chemotherapy in patients with metastatic breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 1088–1088. 1 indexed citations
18.
Yao, Herui, et al.. (2018). Role of neoadjuvant chemotherapy or chemoradiotherapy in oesophageal carcinoma.. Journal of Clinical Oncology. 36(15_suppl). 4040–4040. 1 indexed citations
19.
Wang, Ying, Yunfang Yu, Shengbo Liu, Qiyun Ou, & Herui Yao. (2018). Cyclin-dependent kinases 4 and 6 inhibitors in HR+/HER2- advanced breast cancer.. Journal of Clinical Oncology. 36(15_suppl). e13048–e13048. 2 indexed citations
20.
Zeng, Dongqiang, Yunfang Yu, Qiyun Ou, et al.. (2016). Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer. Oncotarget. 7(12). 13765–13781. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Audrey Hennequin Breakdown of academic impact, for papers by Laure Hirsch Breakdown of academic impact, for papers by Muhammad Zubair Afzal Breakdown of academic impact, for papers by Osvaldo Arén Frontera Breakdown of academic impact, for papers by Emily Roarty Breakdown of academic impact, for papers by Yiming Mao Breakdown of academic impact, for papers by R. Houston Thompson Breakdown of academic impact, for papers by Jonathan Derman Breakdown of academic impact, for papers by Valentina Tateo
Rankless by CCL
2026